Alcoholic Hepatitis Histological Scoring System

The Alcoholic Hepatitis Histological Scoring System predicts 90‑day mortality using fibrosis, neutrophil infiltration, bilirubinostasis, and megamitochondria on biopsy 1.

Fibrosis Stage
No Fibrosis or Portal Fibrosis or Expansive Fibrosis0Bridging fibrosis or Cirrhosis+3
Bilirubinostasis
None/Hepatocellular Only0Canalicular or Ductular+1Canalicular or ductular plus Hepatocellular+2
PMN infiltration
Severe PMN Infiltration0No/Mild PMN Infiltration+2
Megamitochondria
Positive Megamitochondria0No Megamitochondria+2

使用適応

Used when liver biopsy is performed for suspected alcoholic hepatitis with diagnostic uncertainty or for clinical trial enrollment, as biopsy is not routinely required. The score’s utility is prognostic only, estimating 90‑day mortality risk based on four histologic features (fibrosis, neutrophils, bilirubinostasis, megamitochondria) 1 [Level I evidence]. Validation shows risk stratification but no superiority to clinical scores in severe AH 2 [Level II evidence].

洞察と注意事項

Stronger prognostic value comes from fibrosis, neutrophil infiltration, bilirubinostasis type, and megamitochondria; these define low, moderate, and high 90‑day mortality risk (3%, 19%, 51%) 1 [Level I evidence]. However, accuracy is modest, interobserver variability is substantial, and severe AH shows limited short‑term prognostic discrimination 2 [Level II evidence]. Requires biopsy within 48 h and is less practical than clinical scores.